213 related articles for article (PubMed ID: 26032919)
21. Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapy.
Ma WJ; Gu YK; Peng JH; Wang XC; Yue X; Pan ZZ; Chen G; Xu HN; Zhou ZG; Zhang RX
Aging (Albany NY); 2018 Oct; 10(10):2755-2771. PubMed ID: 30341253
[TBL] [Abstract][Full Text] [Related]
22. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
Edden Y; Wexner SD; Berho M
Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH
J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
25. Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now.
MacGregor TP; Maughan TS; Sharma RA
J Clin Pathol; 2012 Oct; 65(10):867-71. PubMed ID: 22734005
[TBL] [Abstract][Full Text] [Related]
26. Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
Molinari C; Matteucci F; Caroli P; Passardi A
Clin Colorectal Cancer; 2015 Dec; 14(4):227-38. PubMed ID: 26170142
[TBL] [Abstract][Full Text] [Related]
27. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
29. miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma.
D'Angelo E; Zanon C; Sensi F; Digito M; Rugge M; Fassan M; Scarpa M; Pucciarelli S; Nitti D; Agostini M
J Clin Pathol; 2018 Apr; 71(4):344-350. PubMed ID: 28870889
[TBL] [Abstract][Full Text] [Related]
30. [Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma].
Garajová I; Svoboda M; Slabý O; Kocáková I; Fabian P; Kocák I; Vyzula R
Klin Onkol; 2008; 21(6):330-7. PubMed ID: 19382596
[TBL] [Abstract][Full Text] [Related]
31. Possible role of nuclear β-catenin in resistance to preoperative chemoradiotherapy in locally advanced rectal cancer.
Takahashi H; Nakamura K; Usami A; Tsuruta T; Hashimura M; Matsumoto T; Saegusa M
Histopathology; 2017 Aug; 71(2):227-237. PubMed ID: 28370249
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.
Dreussi E; Cecchin E; Polesel J; Canzonieri V; Agostini M; Boso C; Belluco C; Buonadonna A; Lonardi S; Bergamo F; Gagno S; De Mattia E; Pucciarelli S; De Paoli A; Toffoli G
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608007
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.
Caramés C; Cristóbal I; Moreno V; del Puerto L; Moreno I; Rodriguez M; Marín JP; Correa AV; Hernández R; Zenzola V; Hernández T; León A; Martín JI; Sánchez-Fayos P; García-Olmo D; Rojo F; Goel A; Fernandez-Aceñero MJ; García-Foncillas J
Int J Colorectal Dis; 2015 Jul; 30(7):899-906. PubMed ID: 25953218
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy.
Du C; Zhao J; Xue W; Dou F; Gu J
Histopathology; 2013 Apr; 62(5):723-30. PubMed ID: 23425253
[TBL] [Abstract][Full Text] [Related]
35. Molecular markers for recurrence and sensitivity to preoperative chemoradiotherapy in locally advanced rectal tumours.
Romain B; Meyer N; Brigand C; Chenard MP; Schneider A; Guenot D
Dig Surg; 2014; 31(4-5):347-53. PubMed ID: 25503074
[TBL] [Abstract][Full Text] [Related]
36. The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
De Palma FDE; Luglio G; Tropeano FP; Pagano G; D'Armiento M; Kroemer G; Maiuri MC; De Palma GD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987896
[TBL] [Abstract][Full Text] [Related]
37. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite Instability Correlated Inflammatory Markers and their Prognostic Value in the Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Hypothesis-generating Study.
Lee JH; Kang BH; Song C; Kang SB; Lee HS; Lee KW; Chie EK; Kim JS
In Vivo; 2020; 34(4):2119-2126. PubMed ID: 32606192
[TBL] [Abstract][Full Text] [Related]
39. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
40. Effect of long interval between hyperthermochemoradiation therapy and surgery for rectal cancer on apoptosis, proliferation and tumor response.
Kato T; Fujii T; Ide M; Takada T; Sutoh T; Morita H; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Oyama T; Kuwano H
Anticancer Res; 2014 Jun; 34(6):3141-6. PubMed ID: 24922685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
